Nano lett
GLP-1 receptor agonists slow gastric emptying, meaning food remains in the stomach longer before moving into the small intestine
The following primary antibodies were used: anti-MC5-R (Alomone Labs, Jerusalem, Israel, # AMR-025), anti--MSH (Bioss, MA, USA, # BS-1848R), anti-phospho-JNK (Cell Signaling Tech, # 4668), anti-JNK (R&D Systems, # AF-1387), anti-phospho-ERK1/2 (Cell Signaling Tech, # 9107), anti-ERK1/2 (Cell Signaling Tech, # 9106), anti-phospho-p38 (Cell Signaling Tech, # 9215), anti-p38 (Cell Signaling Tech, # 9212), anti-phospho-AMPK (Cell Signaling Tech, # 2535), anti-AMPK (Cell Signaling Tech, # 2532), anti-phospho-Akt (R&D Systems, # AF887), anti-Akt (R&D Systems, # MAB2055), anti-phospho-CREB (ThermoFisher, # MA5-11192), anti-CREB (Cell Signaling Tech, #9197) and anti-NT-proBNP (Abcam, # ab13115) antibody
1:1 Functional Medicine Support This option is perfect for you if you have a complex case and you need hands-on support to get to the bottom of your symptoms
Your plan evolves with you, not a one-size-fits-all protocol
Khedr E, Omran E, Ismail N, et al (2017) Effects of transcranial direct current stimulation on pain, mood and serum endorphin level in the treatment of fibromyalgia: A double blinded, randomized clinical trial
